BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35124513)

  • 1. Chalcones from Angelica keiskei (ashitaba) inhibit key Zika virus replication proteins.
    Mottin M; Caesar LK; Brodsky D; Mesquita NCMR; de Oliveira KZ; Noske GD; Sousa BKP; Ramos PRPS; Jarmer H; Loh B; Zorn KM; Foil DH; Torres PM; Guido RVC; Oliva G; Scholle F; Ekins S; Cech NB; Andrade CH; Laster SM
    Bioorg Chem; 2022 Mar; 120():105649. PubMed ID: 35124513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-platelet effects of chalcones from
    Ohkura N; Ohnishi K; Taniguchi M; Nakayama A; Usuba Y; Fujita M; Fujii A; Ishibashi K; Baba K; Atsumi G
    Pharmazie; 2016 Nov; 71(11):651-654. PubMed ID: 29441970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioassay-guided isolation and identification of anti-platelet-active compounds from the root of Ashitaba (Angelica keiskei Koidz.).
    Son DJ; Park YO; Yu C; Lee SE; Park YH
    Nat Prod Res; 2014; 28(24):2312-6. PubMed ID: 25019280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTP1B inhibitors from stems of Angelica keiskei (Ashitaba).
    Li JL; Gao LX; Meng FW; Tang CL; Zhang RJ; Li JY; Luo C; Li J; Zhao WM
    Bioorg Med Chem Lett; 2015; 25(10):2028-32. PubMed ID: 25891102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-Hydroxyderricin and xanthoangelol from Ashitaba (Angelica keiskei) suppress differentiation of preadiopocytes to adipocytes via AMPK and MAPK pathways.
    Zhang T; Sawada K; Yamamoto N; Ashida H
    Mol Nutr Food Res; 2013 Oct; 57(10):1729-40. PubMed ID: 23681764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two chalcones, 4-hydroxyderricin and xanthoangelol, stimulate GLUT4-dependent glucose uptake through the LKB1/AMP-activated protein kinase signaling pathway in 3T3-L1 adipocytes.
    Ohta M; Fujinami A; Kobayashi N; Amano A; Ishigami A; Tokuda H; Suzuki N; Ito F; Mori T; Sawada M; Iwasa K; Kitawaki J; Ohnishi K; Tsujikawa M; Obayashi H
    Nutr Res; 2015 Jul; 35(7):618-25. PubMed ID: 26077869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.
    Gharbi-Ayachi A; Santhanakrishnan S; Wong YH; Chan KWK; Tan ST; Bates RW; Vasudevan SG; El Sahili A; Lescar J
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32796069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six new chalcones from Angelica keiskei inducing adiponectin production in 3T3-L1 adipocytes.
    Ohnogi H; Kudo Y; Tahara K; Sugiyama K; Enoki T; Hayami S; Sagawa H; Tanimura Y; Aoi W; Naito Y; Kato I; Yoshikawa T
    Biosci Biotechnol Biochem; 2012; 76(5):961-6. PubMed ID: 22738967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Bispecific Lead Compounds from
    Kumar S; El-Kafrawy SA; Bharadwaj S; Maitra SS; Alandijany TA; Faizo AA; Khateb AM; Dwivedi VD; Azhar EI
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of New Zika Protease and Polymerase Inhibitors through the Open Science Collaboration Project OpenZika.
    Mottin M; de Paula Sousa BK; de Moraes Roso Mesquita NC; de Oliveira KIZ; Noske GD; Sartori GR; de Oliveira Albuquerque A; Urbina F; Puhl AC; Moreira-Filho JT; Souza GE; Guido RVC; Muratov E; Neves BJ; Martins da Silva JH; Clark AE; Siqueira-Neto JL; Perryman AL; Oliva G; Ekins S; Andrade CH
    J Chem Inf Model; 2022 Dec; 62(24):6825-6843. PubMed ID: 36239304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NS2B-NS3 protease inhibitors as promising compounds in the development of antivirals against Zika virus: A systematic review.
    Nunes DAF; Santos FRDS; da Fonseca STD; de Lima WG; Nizer WSDC; Ferreira JMS; de Magalhães JC
    J Med Virol; 2022 Feb; 94(2):442-453. PubMed ID: 34636434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Potent Zika Virus NS5 RNA-Dependent RNA Polymerase Inhibitors Combining Virtual Screening and Biological Assays.
    Chen Y; Chi X; Zhang H; Zhang Y; Qiao L; Ding J; Han Y; Lin Y; Jiang J
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ashitaba (
    Zhang T; Wang Q; Fredimoses M; Gao G; Wang K; Chen H; Wang T; Oi N; Zykova TA; Reddy K; Yao K; Ma W; Chang X; Lee MH; Rathore MG; Bode AM; Ashida H; Lippman SM; Dong Z
    Cancer Prev Res (Phila); 2018 Oct; 11(10):607-620. PubMed ID: 29980517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chalcones from Angelica keiskei: Evaluation of Their Heat Shock Protein Inducing Activities.
    Kil YS; Choi SK; Lee YS; Jafari M; Seo EK
    J Nat Prod; 2015 Oct; 78(10):2481-7. PubMed ID: 26431394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Chalcone from Ashitaba (
    Kweon M; Lee H; Park C; Choi YH; Ryu JH
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31658768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of 4-hydroxyderricin and xanthoangelol on lipopolysaccharide-induced inflammatory responses in RAW264 macrophages.
    Yasuda M; Kawabata K; Miyashita M; Okumura M; Yamamoto N; Takahashi M; Ashida H; Ohigashi H
    J Agric Food Chem; 2014 Jan; 62(2):462-7. PubMed ID: 24369884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavonoids from Pterogyne nitens as Zika virus NS2B-NS3 protease inhibitors.
    Lima CS; Mottin M; de Assis LR; Mesquita NCMR; Sousa BKP; Coimbra LD; Santos KB; Zorn KM; Guido RVC; Ekins S; Marques RE; Proença-Modena JL; Oliva G; Andrade CH; Regasini LO
    Bioorg Chem; 2021 Apr; 109():104719. PubMed ID: 33636437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxycycline Interferes with Zika Virus Serine Protease and Inhibits Virus Replication in Human Skin Fibroblasts.
    Chong Teoh T; J Al-Harbi S; Abdulrahman AY; Rothan HA
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.
    Yuan S; Chan JF; den-Haan H; Chik KK; Zhang AJ; Chan CC; Poon VK; Yip CC; Mak WW; Zhu Z; Zou Z; Tee KM; Cai JP; Chan KH; de la Peña J; Pérez-Sánchez H; Cerón-Carrasco JP; Yuen KY
    Antiviral Res; 2017 Sep; 145():33-43. PubMed ID: 28712942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic fidaxomicin is an RdRp inhibitor as a potential new therapeutic agent against Zika virus.
    Yuan J; Yu J; Huang Y; He Z; Luo J; Wu Y; Zheng Y; Wu J; Zhu X; Wang H; Li M
    BMC Med; 2020 Jul; 18(1):204. PubMed ID: 32731873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.